Podcast Episodes

Back to Search
Episode 38: Prophy and Pints!

Episode 38: Prophy and Pints!


Season 1 Episode 37


We're back after a summer break! In this episode, Anthony and Bernie review the optimal approach to antimicrobial prophylaxis in hematology patients. How do you best choose prophylaxis for your patie…


Published on 11 hours ago

Episode 37: Spilling Drinks over Cytarabine Dosing

Episode 37: Spilling Drinks over Cytarabine Dosing


Season 1 Episode 37


In this episode, Bernie and Anthony talk about some BIG changes in cytarabine dosing in AML consolidation after a recent practice changing article. Will this change your practice?


Hunault, et al. NEJ…


Published on 1 month, 4 weeks ago

Episode 36: ODAC - Our Decisions Are Confusing

Episode 36: ODAC - Our Decisions Are Confusing


Season 1 Episode 36


In this episode, Bernie and Anthony are joined by the Myeloma Man Dr. Manni Mohyuddin and lymphoma expert Dr. David Russler-Germain to discuss the very recent ODAC decisions on the STARGLO (glofitama…


Published on 3 months, 1 week ago

CSO Encore Video Presentation - SWOG1826 & STARGLO Trials Critically Examined

CSO Encore Video Presentation - SWOG1826 & STARGLO Trials Critically Examined


Season 1 Episode 35


This is a special encore video presentation of Anthony and Bernie teaming up with the Common Sense Oncology Journal Club series to discuss the SWOG1826 and STARGLO clinical trials. Tycel Phillips, MD…


Published on 4 months ago

Dex and the Cytokine City: Managing CRS with Bispecifics

Dex and the Cytokine City: Managing CRS with Bispecifics


Season 1 Episode 34


In this episode, Bernie and Anthony are joined by 3 hematology pharmacists - James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; and Justine Preedit, PharmD, BCOP - to discuss the optimal manag…


Published on 5 months ago

LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML

LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML


Season 1 Episode 33


In this episode, Bernie and Anthony are joined by Dr. Charlie Foucar and Dr. Anand Patel to review the interesting and controversy-filled saga of gemtuzumab in AML? Should we be using this agent in A…


Published on 5 months, 4 weeks ago

Episode 32: Navigating a BlinatumoMAD World

Episode 32: Navigating a BlinatumoMAD World


Season 1 Episode 32


In this episode, Anthony and Bernie are joined by two special guests to discuss recent updates to the use of blinatumomab in both adult and pediatric acute lymphoblastic leukemia (ALL), including the…


Published on 7 months, 2 weeks ago

The Aquila Study: Blowing Hot Air or a Soaring Success for Smoldering Multiple Myeloma

The Aquila Study: Blowing Hot Air or a Soaring Success for Smoldering Multiple Myeloma


Season 1 Episode 31


AQUILA is a constellation shaped like an eagle, and also a hotly debated myeloma trial of daratumumab in smoldering multiple myeloma. In this episode, Bernie and Anthony are joined by myeloma expert …


Published on 7 months, 3 weeks ago

Pour Decisions, or ASH-olutely Fabulous? Reviewing 2024 ASH Lymphoma Updates

Pour Decisions, or ASH-olutely Fabulous? Reviewing 2024 ASH Lymphoma Updates


Season 1 Episode 30


In this episode released just in time for the holidays, Anthony and Bernie are joined by Tycel Phillips, MD to discuss the most exciting updates from ASH 2024 in lymphoma! Pour yourself a drink and h…


Published on 8 months, 2 weeks ago

A Bunch of ASHholes Discuss Myeloma Abstracts

A Bunch of ASHholes Discuss Myeloma Abstracts


Season 1 Episode 29


In this episode, Anthony and Bernie are joined by Dr. Aaron "Papa Heme" Goodman and Dr. Manni "Myeloma Man" Mohyuddin to discuss the most intriguing ASH 2024 abstracts! Should any of the research fro…


Published on 9 months, 3 weeks ago





If you like Podbriefly.com, please consider donating to support the ongoing development.

Donate